Commonwealth of Pennsylvania Public School Empls Retrmt SYS Acquires New Position in Indivior PLC $INDV

Commonwealth of Pennsylvania Public School Empls Retrmt SYS bought a new position in shares of Indivior PLC (NASDAQ:INDV) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm bought 30,910 shares of the company’s stock, valued at approximately $1,109,000.

Other hedge funds also recently made changes to their positions in the company. VIRGINIA RETIREMENT SYSTEMS ET Al boosted its stake in Indivior by 3.4% in the fourth quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 21,200 shares of the company’s stock valued at $761,000 after acquiring an additional 700 shares during the period. Blue Trust Inc. lifted its holdings in shares of Indivior by 17.8% in the 4th quarter. Blue Trust Inc. now owns 4,859 shares of the company’s stock worth $176,000 after purchasing an additional 733 shares during the last quarter. Harbor Capital Advisors Inc. boosted its position in Indivior by 309.9% during the 4th quarter. Harbor Capital Advisors Inc. now owns 1,033 shares of the company’s stock valued at $37,000 after purchasing an additional 781 shares during the period. Salomon & Ludwin LLC acquired a new position in Indivior during the 4th quarter valued at approximately $30,000. Finally, GAMMA Investing LLC grew its stake in Indivior by 544.6% during the 4th quarter. GAMMA Investing LLC now owns 1,199 shares of the company’s stock worth $43,000 after buying an additional 1,013 shares during the last quarter. Institutional investors and hedge funds own 60.33% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on INDV. Zacks Research upgraded shares of Indivior from a “hold” rating to a “strong-buy” rating in a research report on Monday, March 16th. Weiss Ratings lowered shares of Indivior from a “hold (c+)” rating to a “hold (c)” rating in a research note on Wednesday, May 6th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $39.33.

Indivior Stock Performance

Shares of NASDAQ:INDV opened at $37.39 on Tuesday. The stock has a market capitalization of $4.56 billion, a price-to-earnings ratio of 19.17 and a beta of 0.88. Indivior PLC has a 1-year low of $13.42 and a 1-year high of $41.00. The company has a 50 day moving average price of $34.76 and a 200 day moving average price of $34.15.

Indivior (NASDAQ:INDV) last posted its quarterly earnings results on Tuesday, March 31st. The company reported $0.96 earnings per share (EPS) for the quarter. The company had revenue of $317.00 million for the quarter. Indivior had a negative return on equity of 219.26% and a net margin of 19.44%. On average, sell-side analysts expect that Indivior PLC will post 4.05 EPS for the current fiscal year.

Indivior Company Profile

Indivior plc is a specialty pharmaceutical company dedicated to developing and delivering treatments for addiction and related mental health disorders. The company’s portfolio centers on therapies designed to support individuals dealing with opioid dependence, alcohol use disorder and other behavioral health challenges. Its lead products include Suboxone® (buprenorphine and naloxone) sublingual film and Sublocade® (extended-release buprenorphine) injection, both of which are approved in multiple markets to aid in opioid use disorder management.

Indivior was established in 2014 through a demerger from the pharmaceuticals division of Reckitt Benckiser Group plc, inheriting decades of research and commercial expertise in addiction medicine.